| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-026 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
1998-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2002-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2002504808-A |
| titleOfInvention |
Compositions and methods for diagnosing / treating diseases based on β-catenin / transcription factor interaction |
| abstract |
(57) [Summary]nUseful methods and compositions for diagnosing and / or treating diseases, preferably cancers, resulting from unwanted cell proliferation, comprising diagnosing cells for stabilized β-catenin or comprising a combination of β-catenin / transcription factors. Methods and compositions are described that relate to treating cells with compounds that disrupt or alter body formation. Here, the transcription factor is a member of the Lef / Tcf family. |
| priorityDate |
1997-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |